Exceed ABT Cemented E1 Non Flanged Cup - Polyethylene acetabulum prosthesis Australia - English - Department of Health (Therapeutic Goods Administration)

exceed abt cemented e1 non flanged cup - polyethylene acetabulum prosthesis

zimmer biomet pty ltd - 34076 - polyethylene acetabulum prosthesis - acetabular cup component of hip joint replacement prostheses. made from highly cross linked molecular weight polyethylene with ?-tocopherol. includes polymethylmethacrylate cement spacers and titanium x-ray marker wire. for cemented use. the exceed abt cemented non flanged cup is part of the exceed abt hip system and is intended for use in total hip arthroplasty. the indications for the use include: non-inflammatory degenerative joint diseases including osteoarthritis, avascular necrosis and post-traumatic arthritis. rheumatoid arthritis. correction of functional deformity. revision of failed joint reconstruction or treatment. treatment of femoral neck and trochanteric fractures of the proximal femur with femoral head involvement and which are unmanageable using other techniques.

Exceed ABT Cemented E1 Muller Cup - Polyethylene acetabulum prosthesis Australia - English - Department of Health (Therapeutic Goods Administration)

exceed abt cemented e1 muller cup - polyethylene acetabulum prosthesis

zimmer biomet pty ltd - 34076 - polyethylene acetabulum prosthesis - acetabular cup component of hip joint replacement prostheses. made from highly cross linked molecular weight polyethylene with ?-tocopherol. includes titanium x-ray marker wire. for cemented use. the exceed abt cemented muller cup is part of the exceed abt hip system and is intended for use in total hip arthroplasty. the indications for the use include: non-inflammatory degenerative joint diseases including osteoarthritis, avascular necrosis and post-traumatic arthritis. rheumatoid arthritis. correction of functional deformity. revision of failed joint reconstruction or treatment. treatment of femoral neck and trochanteric fractures of the proximal femur with femoral head involvement and which are unmanageable using other techniques.

MABTHERA INFUSION (CONCENTRATE) Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

mabthera infusion (concentrate)

rituximab 500mg/150ml

Mabthera IV Solution For Infusion 500 mg/50ml Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

mabthera iv solution for infusion 500 mg/50ml

al jishi pharmacy - rituximab - iv solution for infusion - 500

Mabthera IV Solution For Infusion 100 mg/10ml Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

mabthera iv solution for infusion 100 mg/10ml

al jishi pharmacy - rituximab - iv solution for infusion - 100

Mabthera 1400 mg/ 11.7 mL Solution For Injection (SC) Philippines - English - FDA (Food And Drug Administration)

mabthera 1400 mg/ 11.7 ml solution for injection (sc)

n/a; importer: roche (philippines) inc.; distributor: roche (philippines) inc. - rituximab - solution for injection (sc) - 1400 mg/ 11.7 ml

Mabthera 10 mg/ mL Concentrate For Solution For Infusion (IV) Philippines - English - FDA (Food And Drug Administration)

mabthera 10 mg/ ml concentrate for solution for infusion (iv)

roche (philippines), inc.; distributor: zuellig pharma corporation - rituximab - concentrate for solution for infusion (iv) - 10 mg/ ml

Mabthera 1400mg + 11.7mL Solution for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

mabthera 1400mg + 11.7ml solution for injection (sc)

zuellig pharma corporation - rituximab - solution for injection (sc) - 1400mg + 11.7ml

MABTHERA 100 Zimbabwe - English - Medicines Control Authority

mabthera 100

roche products - rituximab - solution; infusion - 10mg/ml

MABTHERA 500 Zimbabwe - English - Medicines Control Authority

mabthera 500

roche products - rituximab - injectable; injection - 10 mg/ml